Melanoma Clinical Trials

Showing 601-620 of 1,292 trials

Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

NCT03060356

This is a pilot study to evaluate feasibility, safety, and preliminary evidence of efficacy for intravenously administered, RNA electroporated autologous T cells expressing MET chimeric antigen receptors with tandem TCRζ and 4-1BB (TCRζ /4-1BB) co-stimulatory domains (referred to as "RNA CART-cMET") in patients with advanced melanoma or breast carcinoma.

Malignant MelanomaBreast Cancer

University of Pennsylvania77 participantsStarted Dec 2016

Philadelphia, Pennsylvania, United States

UNKNOWN

Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma

NCT05889481

The objectives of the study are the morpho-phenotypic evaluation of uveal melanoma and to identify molecular prognostic factors that may be correlated with disease severity, tumour progression and response to treatment. These objectives will be achieved through immunohistochemical and genetic analyses.

Uveal Melanoma

Fondazione Policlinico Universitario Agostino Gemelli IRCCS100 participantsStarted Jan 2008

Rome, Italy

Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma

Related Searches

Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome

Biobanking and New Biomolecular Metrics

Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)

Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma

Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping

Fibrin Melanoma Axillary Node Study in Patients With Melanoma

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

Healthcare Resource Utilization and Costs in Metastatic Melanoma Patients Initiated Dabrafenib + Trametinib and Encorafenib + Binimetinib

Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors

Safety Study of SEA-CD40 in Cancer Patients

KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma

Bangladesh Vitamin E and Selenium Trial

A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma

Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma

Patient Characteristics, Associated Factors, and Clinical Outcomes of Prescribing Encorafenib and Binimetenib Versus Dabrafenib and Trametinib Among BRAF v600 Mutated Metastatic Melanoma Patients